The Chinese patent office, the State Intellectual Property Office (SIPO), has formally approved Cantargia AB's patent application for IL1RAP as a target molecule for
antibody therapy of several solid tumour types, the company disclosed on Friday.
Nexvet's pipeline product ranevetmab, a mAb targeting nerve-growth factor for treatment of chronic pain associated with osteoarthritis in dogs, would, upon approval, be the companion animal industry's first monoclonal
antibody therapy administered monthly by injection for chronic pain.
Nexvets pipeline product ranevetmab, a mAb targeting nerve-growth factor (NGF) for treatment of chronic pain associated with osteoarthritis in dogs, would, upon approval, be the companion animal industrys first monoclonal
antibody therapy administered monthly by injection for chronic pain.
ST) announced on Wednesday that the US Patent and Trademark Office (USPTO) has issued a Notice of Allowance on Its patent application regarding IL1RAP as a target molecule for
antibody therapy of acute lymphatic leukaemia (ALL).
Filings: XBiotech has been granted Fast Track Designation for its novel True Human monoclonal
antibody therapy intended to treat all forms of Staphylococcus aureus infections, including Methicillin-resistant S.
We are really excited by the advent of
antibody therapy for canine lymphoma," says Cheryl Balkman, DVM, ACVIM, senior lecturer and chief of oncology at Cornell University College of Veterinary Medicine.
The SBIR grant will fund a project entitled "The Creation of a Human Recombinant Polyclonal
Antibody Therapy against C.
Louis Weiner, director of the cancer centre at GUMC, says that monoclonal
antibody therapy of cancer can be improved to be much more powerful than it is today with modifications.
Dr Wayne Marasco, of Harvard Medical School in Boston, found
antibody therapy provides a new way of fighting the disease.
Founded in 2000 by Ian Tomlinson and Sir Gregory Winter, Domantis has pioneered the next generation of
antibody therapy, which is based on the smallest functional binding units of human antibodies.
There is potential for a better overall response when these agents are combined with monoclonal
antibody therapy (e.
Several groups of scientists are now studying whether a few days or weeks of
antibody therapy, if given soon after diagnosis of type 1 diabetes, can keep the disease from worsening.
